Glenn Goddard
Director of Finance/CFO at INTELLIA THERAPEUTICS, INC.
Net worth: 2 M $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Andrew Schiermeier | M | 54 |
AvenCell Therapeutics, Inc.
 AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | 6 years |
| John Leonard | M | 66 | 10 years | |
| Frank Verwiel | M | 62 | 7 years | |
| Paris Panayiotopoulos | M | 50 |
AvenCell Therapeutics, Inc.
AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | 3 years |
| Muna Bhanji | F | 61 | 2 years | |
| Georgia Keresty | M | 62 | 3 years | |
| James Basta | M | 58 | 3 years | |
| Ian Karp | M | - | - | |
| Jesse Goodman | M | 72 | 6 years | |
| Kaye Foster-Cheek | F | 64 | 10 years | |
| William Chase | M | 57 | 1 years | |
| Fred Cohen | M | 67 | 5 years | |
| May Kin Ho | M | 71 | 9 years | |
| Markus Orchowski | M | - |
AvenCell Therapeutics, Inc.
AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | 2 years |
| Olivier Brandicourt | M | 68 |
AvenCell Therapeutics, Inc.
AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | - |
| Gerhard Ehninger | M | - |
AvenCell Therapeutics, Inc.
AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | 3 years |
| David Lebwohl | M | 69 | 4 years | |
| Axel Gaston Glasmacher | M | 64 |
AvenCell Therapeutics, Inc.
AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | 3 years |
| Li Lina | F | - | - | |
| Jim Burns | M | 46 | 8 years | |
| Ari Brettman | M | 42 |
AvenCell Therapeutics, Inc.
AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | 3 years |
| Laura Sepp-Lorenzino | M | 63 | 5 years | |
| Marika St Amand | F | - | - | |
| Eliana Clark | M | 67 | - | |
| Derek Hicks | M | 51 | 3 years | |
| Aron Stein | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Perry Karsen | M | 69 | 9 years | |
| Kevin Starr | M | 61 | 7 years | |
| Jose Rivera | M | 58 | 6 years | |
| Jean-Francois Formela | M | 67 | 9 years | |
| Marc Tessier-Lavigne | M | 64 | 5 years | |
| John Crowley | M | 57 | 3 years | |
| Caroline Dorsa | F | 64 | 8 years | |
| Megan E. Pace | F | 51 | - | |
| Paul Clancy | M | 62 | 10 years | |
| Darrin Miles | M | - | 6 years | |
| Samuel Agresta | M | 51 | 7 years | |
| Jacqueline Cinicola | F | - | 7 years | |
| Kevin Marks | M | - | 2 years | |
| Eyal Attar | M | 53 | 5 years | |
| Christine Foster | M | - | - | |
| Jennifer Mound Smoter | F | - | 6 years | |
| Richa Poddar | F | - | 6 years | |
| Ann J. Barbier | M | 59 | 2 years | |
| Scott Biller | M | 68 | 9 years | |
| Renee T. Leck | F | - | 3 years | |
| Melissa McLaughlin | F | - | 7 years | |
| Robert Sheroff | M | 69 | 2 years | |
| Camille Henderson | M | - | 4 years | |
| Christopher Bowden | M | 63 | 7 years | |
| Marion Dorsch | M | 59 | 4 years | |
| Robert J. DeVita | M | - | - | |
| Andrew Hirsch | M | 53 | 4 years | |
| John Duncan Higgons | M | 69 | 7 years | |
| Meredith Goldwasser | M | 52 | 6 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 55 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Glenn Goddard
- Personal Network